AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Li, RH Wozney, JM
Citation: Rh. Li et Jm. Wozney, Delivering on the promise of bone morphogenetic proteins, TRENDS BIOT, 19(7), 2001, pp. 255-265

Authors: Hunt, DR Jovanovic, SA Wikesjo, UME Wozney, JM Bernard, GW
Citation: Dr. Hunt et al., Hyaluronan supports recombinant human bone morphogenetic protein-2 inducedbone reconstruction of advanced alveolar ridge defects in dogs. A pilot study, J PERIODONT, 72(5), 2001, pp. 651-658

Authors: Bouxsein, ML Turek, TJ Blake, CA D'Augusta, D Li, X Stevens, M Seeherman, HJ Wozney, JM
Citation: Ml. Bouxsein et al., Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model, J BONE-AM V, 83A(8), 2001, pp. 1219-1230

Authors: Uludag, H Gao, TJ Porter, TJ Friess, W Wozney, JM
Citation: H. Uludag et al., Delivery systems for BMPs: Factors contributing to protein retention at anapplication site, J BONE-AM V, 83A, 2001, pp. S128-S135

Authors: Wikesjo, UME Sorensen, RG Wozney, JM
Citation: Ume. Wikesjo et al., Augmentation of alveolar bone and dental implant osseointegration: Clinical implications of studies with rhBMP-2 - A comprehensive review, J BONE-AM V, 83A, 2001, pp. S136-S145

Authors: Meyer, RA Gruber, HE Howard, BA Tabor, OB Murakami, T Kwiatkowski, TC Wozney, JM Hanley, EN
Citation: Ra. Meyer et al., Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog, SPINE, 25(6), 2000, pp. 115S-122S

Authors: Lee, KS Kim, HJ Li, QL Chi, XZ Ueta, C Komori, T Wozney, JM Kim, EG Choi, JY Ryoo, HM Bae, SC
Citation: Ks. Lee et al., Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12, MOL CELL B, 20(23), 2000, pp. 8783-8792

Authors: Uludag, H D'Augusta, D Golden, J Li, J Timony, G Riedel, R Wozney, JM
Citation: H. Uludag et al., Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model, J BIOMED MR, 50(2), 2000, pp. 227-238

Authors: Steinberg, B Chiego, DJ Huizinga, PJ Wozney, JM Wikesjo, UME
Citation: B. Steinberg et al., Effect of human bone morphogenetic protein 2 implant on tooth eruption in an experimental design, J CRANIOF S, 10(4), 1999, pp. 338-341

Authors: Cochran, DL Wozney, JM
Citation: Dl. Cochran et Jm. Wozney, Biological mediators for periodontal regeneration, PERIODONTOL, 19, 1999, pp. 40-58

Authors: Meyer, RA Gruber, HE Howard, BA Tabor, OB Murakami, T Kwiatkowski, TC Wozney, JM Hanley, EN
Citation: Ra. Meyer et al., Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog, SPINE, 24(8), 1999, pp. 747-754

Authors: David, SM Gruber, HE Meyer, RA Murakami, T Tabor, OB Howard, BA Wozney, JM Hanley, EN
Citation: Sm. David et al., Lumbar spinal fusion using recombinant human bone morphogenetic protein inthe canine - A comparison of three dosages and two carriers, SPINE, 24(19), 1999, pp. 1973-1979

Authors: Wikesjo, UME Guglielmoni, P Promsudthi, A Cho, KS Trombelli, L Selvig, KA Jin, L Wozney, JM
Citation: Ume. Wikesjo et al., Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment, J CLIN PER, 26(6), 1999, pp. 392-400

Authors: Bax, BE Wozney, JM Ashhurst, DE
Citation: Be. Bax et al., Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia, CALCIF TIS, 65(1), 1999, pp. 83-89

Authors: Cochran, DL Schenk, R Buser, D Wozney, JM Jones, AA
Citation: Dl. Cochran et al., Recombinant human bone morphogenetic: Protein-2 stimulation of bone formation around endosseous dental implants, J PERIODONT, 70(2), 1999, pp. 139-150

Authors: Boyan, BD Lohmann, CH Somers, A Niederauer, GG Wozney, JM Dean, DD Carnes, DL Schwartz, Z
Citation: Bd. Boyan et al., Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo, J BIOMED MR, 46(1), 1999, pp. 51-59

Authors: Uludag, H Golden, J Palmer, R Wozney, JM
Citation: H. Uludag et al., Biotinated bone morphogenetic protein-2: In vivo and in vitro activity, BIOTECH BIO, 65(6), 1999, pp. 668-672

Authors: Wozney, JM
Citation: Jm. Wozney, Biology and clinical applications of rhBMP-2, TISSUE ENGINEERING, 1999, pp. 103-123

Authors: Schwartz, Z Somers, A Mellonig, JT Carnes, DL Wozney, JM Dean, DD Cochran, DL Boyan, BD
Citation: Z. Schwartz et al., Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone productive implant material, J PERIODONT, 69(12), 1998, pp. 1337-1345
Risultati: 1-19 |